Source: Business Wire

Press Release: Strides : Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries

BEVERLY, Mass. & BANGALORE, India--(BUSINESS WIRE)-- #AKS452--Akston Biosciences & Biolexis collaborate to launch a room temperature stable 2nd-gen COVID vaccine in 130+ countries; expects EUA in India June 2022

Read full article »
Annual Revenue
$500M-1.0B
Employees
1.0-5.0K
CEO Avatar

CEO

- -

CEO Approval Rating

- -/100

Read more